Head-to-head
MEDVi vs Eden
Compared on both medications across the eight dimensions this database records. They differ on 5 of those eight. MEDVi is cheaper on all-in tirzepatide at 10 mg/week, though on a flat-versus-tiered matchup the cheaper program can change further up the dose ladder.
The short answer
MEDVi is $399 a month all-in for tirzepatide; Eden is $507. Over twelve months that is $4,788 against $6,084. Value Scores are 57.4 and 36.1 out of 100.
Tirzepatide
Plan pages: MEDVi plans · Eden plans
At 10 mg/week, MEDVi is $399 a month all-in and Eden is $507 — $108 apart, or $1,296 across a year. Over twelve months the totals are $4,788 (billed monthly) and $6,084 (billed monthly).
MEDVi charges a flat $399 per month for tirzepatide at every dose from 2.5 to 15 mg per week, so titrating upward does not change what you pay.
Eden prices tirzepatide by dose: $348 per month at 2.5 mg rising to $408 at 10 mg, a difference of $60 a month between the bottom and top of the ladder. The company publishes no price at 5, 7.5, 12.5, 15 mg, so those doses are left blank rather than estimated.
| Dose | MEDVi | Rank | Eden | Rank | Cheaper |
|---|---|---|---|---|---|
| 2.5 mg | $399 | 27/31 | $348 | 23/31 | Eden by $51 |
| 5 mg | $399 | 15/17 | — | — | only MEDVi publishes |
| 7.5 mg | $399 | 14/17 | — | — | only MEDVi publishes |
| 10 mg | $399 | 21/27 | $408 | 23/27 | MEDVi by $9 |
| 12.5 mg | $399 | 14/17 | — | — | only MEDVi publishes |
| 15 mg | $399 | 14/17 | — | — | only MEDVi publishes |
The lead changes with the dose. Between 2.5 mg and 10 mg it passes to MEDVi. Pick on the dose you expect to settle at, not the headline.
Across the 27 programs this database can rank on tirzepatide, MEDVi sits 21 of 27 on all-in monthly cost and Eden sits 24. There are 2 other programs priced between them. The field median is $339 and the floor is $169, so both sit above the median. MEDVi is $230 above the cheapest tirzepatide program on record. Eden is $338 above the cheapest tirzepatide program on record.
LillyDirect (Zepbound), the lowest FDA-approved tirzepatide channel here, is $449 a month — MEDVi undercuts it by $50, Eden by $-58. Compounded products are not FDA approved; insurance can reverse that comparison.
| Plan term | MEDVi | Eden | Cheaper |
|---|---|---|---|
| Month to month | $399 | $408 | MEDVi by $9 |
| Settled dose | MEDVi | Eden | Difference |
|---|---|---|---|
| 2.5 mg | $4,788 | $5,364 | $576 apart |
| 5 mg | $4,788 | — | one side unpriced |
| 7.5 mg | $4,788 | — | one side unpriced |
| 10 mg | $4,788 | $6,084 | $1,296 apart |
| 12.5 mg | $4,788 | — | one side unpriced |
| 15 mg | $4,788 | — | one side unpriced |
MEDVi publishes no rate for 3-month term, 6-month term, 12-month term; Eden publishes none for 3-month term, 6-month term, 12-month term. An unpublished term is not necessarily unavailable — it is unpriced in public, which you can only resolve by asking.
A titration year is not twelve months at the maintenance price. Stepping up roughly four weeks per dose before settling at 10 mg/week, the first twelve months work out to $4,788 on MEDVi and $6,024 on Eden — $1,236 apart, and a different gap from the $1,296 you would get by multiplying the monthly difference by twelve. The ramp is cheaper than the settled rate on whichever program prices by dose, which is why a first-year quote and a steady-state quote are not the same number.
That calculation is partial: Eden publishes no price at 2 of them, so the maintenance rate stands in for the missing steps rather than a number the company has stated.
Value Scores are 57.4 for MEDVi and 36.1 for Eden, against a tirzepatide category floor of $169. MEDVi leads by 21.3 points, and the margin comes from structure rather than price alone.
| Program | Price /70 | Evidence /15 | Dose /10 | Membership /5 | Total /100 |
|---|---|---|---|---|---|
| MEDVi | 29.6 | 12.8 | 10 | 5 | 57.4 |
| Eden | 23.3 | 12.8 | 0 | 0 | 36.1 |
Semaglutide
Plan pages: MEDVi plans · Eden plans
At 2.4 mg/week, MEDVi is $299 a month all-in and Eden is $297 — $2 apart, or $24 across a year. Over twelve months the totals are $3,588 (billed monthly) and $3,564 (billed monthly).
MEDVi charges a flat $299 per month for semaglutide at every dose from 0.25 to 2.4 mg per week, so titrating upward does not change what you pay.
Eden charges a flat $198 per month for semaglutide at every dose from 0.25 to 2.4 mg per week, so titrating upward does not change what you pay.
Eden is cheaper at every dose where both publish a price, so the lead does not change as you titrate.
Value Scores are 58.0 for MEDVi and 43.2 for Eden, against a semaglutide category floor of $129. MEDVi leads by 14.8 points, and the margin comes from structure rather than price alone.
Where the two programs differ
All-in monthly
MEDVi is cheaper month to month — $399 against $507, a gap of $108 every month, or $1,296 across a year if both rates hold.
Cancellation terms
Cancellation differs: MEDVi states Cancel before renewal, while Eden states Cancel anytime. Read this next to the twelve-month figures — a prepaid discount and a restrictive refund policy are the same decision.
Dose policy
MEDVi charges one price at every dose; Eden prices by dose. That difference usually matters more than the headline gap, because the tiered program's advertised figure describes the dose you start on, not the dose you settle at.
Membership fee
Eden charges a membership of $99 a month on top of the medication. That is already folded into the all-in figures above — it is broken out here because a membership is a recurring charge that continues even in a month you skip a shipment.
Twelve-month cost
Over twelve months the totals are $4,788 for MEDVi and $6,084 for Eden. MEDVi is lower by $1,296 — a figure worth checking against the cancellation terms below, because a prepaid year is only cheaper if you stay on it.
Commitment
Commitment terms read the same on both: Month-to-month.
Evidence status
Both figures carry the same evidence status, provider-stated: taken from the provider's own published pages; checkout capture pending. Neither is stronger than the other on provenance.
Shipping
Shipping is handled the same way by both — included in the quoted price.
What each record says
MEDVi Official site
MEDVi advertises a $179 semaglutide start that tiers to $299 at maintenance; tirzepatide is $399 flat.
It does not publicly name its compounding pharmacy; the record shows Partner pharmacies, so who actually makes the medication cannot be independently verified; commitment terms are Month-to-month; cancellation is Cancel before renewal; availability is stated as Most US states.
Evidence: provider-stated — taken from the provider's own published pages; checkout capture pending, captured . Source — medvi.com pricing capture 2026-08-05
Watch: Start-vs-maintenance spread on semaglutide; compare on maintenance.
Eden Official site
Eden attaches a $99/month membership to tiered medication pricing; all-in figures land at $198 semaglutide and $408 tirzepatide at maintenance.
It does not publicly name its compounding pharmacy; the record shows Partner pharmacies, so who actually makes the medication cannot be independently verified; commitment terms are Month-to-month; cancellation is Cancel anytime; availability is stated as Most US states.
Evidence: provider-stated — taken from the provider's own published pages; checkout capture pending, captured . Source — tryeden.com pricing capture 2026-08-05
Watch: Membership plus dose tiering makes Eden's advertised numbers diverge sharply from all-in cost.
What neither record tells you
MEDVi does not publish
- no published twelve-month tirzepatide rate
- no published twelve-month semaglutide rate
- no named compounding pharmacy
- no state-by-state availability list — it says Most US states
Eden does not publish
- no tirzepatide price at 5, 7.5, 12.5, 15 mg per week
- no published twelve-month tirzepatide rate
- no published twelve-month semaglutide rate
- no named compounding pharmacy
- no state-by-state availability list — it says Most US states
Ask MEDVi and Eden for each of those in writing before enrolling. A gap is not evidence of a problem; it does mean nothing can be checked against it.
What would change this answer
Neither program publishes a promotional rate with an end date, a prepaid term, or a price we have flagged for re-verification, so the comparison above is as stable as this dataset gets.
Which one suits which reader
On the lowest standing monthly rate for tirzepatide, MEDVi Official site wins this matchup. If you expect to titrate to the top of the ladder, medvi's flat pricing is worth more than the headline gap suggests; if you want to be able to pause without still paying, medvi carries no membership.
Both figures should be checked at the provider's own checkout before you pay. MEDVi's tirzepatide price is provider-stated as of 2026-08-05; Eden's is provider-stated as of 2026-08-05.
Questions
Is MEDVi or Eden cheaper for tirzepatide?
MEDVi is cheaper on all-in monthly cost at 10 mg/week: $399 against $507, a difference of $108 a month. All-in means the medication plus every mandatory recurring fee.
What is the twelve-month cost of MEDVi versus Eden?
MEDVi works out to $4,788 across twelve months and Eden to $6,084, on the plan terms each publishes.
Does MEDVi or Eden raise the price as the dose goes up?
MEDVi: no, it charges one flat rate at every dose. Eden: yes, it prices by dose. Where one program is flat and the other is tiered, the cheaper of the two can change as you titrate upward.
How many ways do MEDVi and Eden differ?
5 of the eight dimensions this site records: all-in monthly, twelve-month cost, dose policy, membership, shipping, commitment, cancellation terms and evidence status.
Which of MEDVi and Eden names its pharmacy?
Neither. MEDVi records Partner pharmacies and Eden records Partner pharmacies. Without a named pharmacy, neither program's licensing or inspection history can be checked before you order.
How well evidenced are the MEDVi and Eden prices?
MEDVi's tirzepatide figure is provider-stated — taken from the provider's own published pages; checkout capture pending — captured 2026-08-05. Eden's is provider-stated, captured 2026-08-05. Evidence status is worth fifteen points in the Value Score, so it is priced in rather than mentioned as an aside.
Which is cheaper for semaglutide?
Eden, at $297 a month all-in against $299 at 2.4 mg/week. The two programs do not necessarily lead on both medications.
Official sources: MEDVi official site · Eden official site. Compounded tirzepatide and semaglutide are not FDA-approved products.